The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index; 8 of the 24 sources its claims cite were checked for support.
ACTH and prolactin synergistically and selectively regulate CYP17 expression and adrenal androgen production in human foetal adrenal organ cultures
Open accessAbstract
Objective: The essential role of ACTH on the growth and function of the human foetal adrenal (HFA) has long been recognized. In addition, many studies have suggested a role of the pituitary hormone prolactin (PRL) in the regulation of the HFA, but the effects of this hormone on steroidogenesis and gene expression are still unknown. Our objective was to investigate the effect of ACTH and PRL on the steroidogenic capacities of the HFA. Design: In vitro/ex vivo experimental study. Methods: We used a hanging drop in vitro organ culture system. First trimester HFA samples were cultured for 14 days in basal conditions or treated with ACTH, PRL, or a combination of the 2 (3 to 11 replicates depending on the experiment). Steroids were measured by liquid chromatography/tandem mass spectrometry or immunoassay, gene expression by RT-qPCR, and protein expression by immunoblot. Results: ACTH significantly increased corticosterone, cortisol, and cortisone production, both by itself and when used together with PRL. PRL stimulation by itself had no effect. Combined stimulation with ACTH + PRL synergistically and selectively increased adrenal androgen (DHEAS and Δ4-androstenedione) production and CYP17A1 expression in the HFA, while treatment with each single hormone had no significant effect on those steroids. Conclusions: These results have important implications for our understanding of the hormonal cues regulating adrenal steroidogenesis in the HFA during the first trimester in physiological and pathological conditions and warrant further studies to characterize the molecular mechanisms of converging ACTH and PRL signalling to regulate CYP17A1 expression.
Overview
CoChat Summary
TL;DR
In human foetal adrenal organ cultures from first-trimester samples, combined ACTH and prolactin treatment selectively and synergistically increased DHEAS and ∆4-androstenedione production and CYP17A1 mRNA/protein, whereas ACTH alone increased glucocorticoid production and prolactin alone had no effect. The findings suggest converging ACTH/prolactin signalling regulates adrenal androgen synthesis in the human foetal adrenal.
Key findings
- ACTH (1 nM) alone or with prolactin (500 ng/ml) significantly increased corticosterone, cortisol, and cortisone production; prolactin alone had no significant effect on any measured steroid.
- Combined ACTH+prolactin selectively and synergistically increased DHEAS and ∆4-androstenedione production and CYP17A1 expression; neither hormone alone significantly affected these androgens. DHEAS was the most abundant steroid produced (hundreds of micromolar), while other steroids ranged from nanomolar to micromolar.
- ACTH increased CYP11B1 expression, prolactin increased CISH expression, and combined ACTH+prolactin selectively increased CYP17A1 mRNA and protein. No significant effects were seen on progesterone, 17-hydroxyprogesterone, 11-deoxycortisol, testosterone, BrdU-positive cells, or cleaved PARP.
- The study used 11 independent HFA cultures (7 male, 4 female); steroid measurements had 4–11 biological replicates, gene expression 9 biological replicates, and protein expression 3 biological replicates, with significance set at p < .05.
Methods
- In vitro/ex vivo experimental study using hanging drop HFA organ cultures from first-trimester foetuses (8–13 GW), cut into ~1 mm³ pieces and cultured for 14 days in basal medium or with ACTH (1 nM), prolactin (500 ng/ml), or ACTH+prolactin; medium was replaced every 2–3 days and pooled during the second week.
- Steroids were measured by LC-MS/MS or immunoassay (DHEAS), normalized to fragment weight and expressed as fold of basal; gene expression was measured by RT-qPCR using PPIA as reference; CYP17A1 protein was measured by immunoblot normalized to GAPDH; IHC was used for zonal/proliferation markers.
- Statistical analysis used one-way ANOVA with Dunnett’s multiple comparisons test for steroid concentrations and CYP17A1 protein, and REST for RT-qPCR, with p < .05 considered significant.
Limitations
- Stated: experiments were performed in first-trimester HFA cultures and only over a relatively limited 14-day in vitro period; circulating prolactin rises from the second trimester onward, so chronic effects on later foetal adrenal growth and steroidogenesis remain untested. The authors also note that first-trimester placental lactogen may mimic prolactin effects on the HFA, and they discuss a discrepancy with Melau et al. possibly due to different ACTH peptide potency or prolactin in foetal bovine serum.
- Evident: CYP17A1 protein data rely on only 3 biological replicates; no sex-specific analysis is reported despite 7 male and 4 female samples; the molecular mechanism of converging ACTH/prolactin signalling to regulate CYP17A1 was not characterized; and the in vitro organ culture system may not fully reflect in vivo physiology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
7 Valid · 1 Not valid · 2 Not checked · 18 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, our data differ from the results reported in the Melau et al . study 16 , which showed that ACTH alone was able to increase the levels of all measured steroids (including DHEAS and ∆ 4-androstenedione) in HFA organ cultures using the same hanging drop system we used in our study.”
What the sources say
- Supportedcites [16] Melau, 2021, Establishment of a novel human fetal adrenal culture model that supports de novo and manipulated steroidogenesis, J Clin Endocrinol Metab source
The Results section reports that ACTH treatment increased measured steroid metabolites in human fetal adrenal tissue cultures, including DHEAS and androstenedione. The Methods section identifies the culture system as hanging drops. The cited paper cannot establish whether the citing authors' own data differ, but it supports the result they attribute to Melau et al. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“These data are also consistent with the in vivo studies cited before showing that PRL has a selective stimulatory effect on adrenal androgen production 12,23-29 .”
What the sources say
- Supportedcites [12] Lalli, 2022, Prolactin as an adrenocorticotropic hormone: prolactin signalling is a conserved key regulator of sexually dimorphic adrenal gland function in health and disease, Bioessays source
The Human studies section reports increased DHEAS production in patients with prolactin-secreting adenomas and significant DHEAS elevation in the authors’ patient cohort, while other measured steroids were not significantly changed. The Hypothesis section summarizes the human evidence as selective regulation of adrenal androgen (DHEAS) production by PRL. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [23] Kang, 2014, Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks, Mol Cell Biol source
- Not checked — no full text of the sourcecites [24] Bassi, 1977, Plasma androgens in women with hyperprolactinaemic amenorrhoea, Clin Endocrinol source
- Not checked — no full text of the sourcecites [25] Vermeulen, 1977, Effect of prolactin on plasma DHEA(S) levels, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [26] Carter, 1977, Adrenocortical function in hyperprolactinemic women, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [27] Vermeulen, 1978, Prolactin and adrenal androgen secretion, Clin Endocrinol source
- Not checked — no full text of the sourcecites [28] Kandeel, 1978, Androgen and cortisol responses to ACTH stimulation in women with hyperprolactinaemia, Clin Endocrinol source
- Not checked — no full text of the sourcecites [29] Lobo, 1980, Prolactin modulation of dehydroepiandrosterone sulfate secretion, Am J Obstet Gynecol source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“We recently showed that, among all adrenal steroids, DHEAS levels are selectively increased in patients with PRL-secreting pituitary adenomas (PRLA) compared with patients with hormonally inactive pituitary adenomas and that they significantly decrease after dopamine agonists therapy, suggesting a direct effect of PRL in the regulation of DHEAS production 15 .”
What the sources say
- Supportedcites [15] Ruggiero, 2021, Integrative genomic analysis reveals a conserved role for prolactin signalling in the regulation of adrenal function, Clin Transl Med source
The paper’s patient comparison (Figure 4A) reports significantly higher DHEAS in patients with PRL-secreting adenomas than in those with non-functioning adenomas. The accompanying discussion describes high PRL as preferentially increasing DHEAS; Figure 4F also reports a decrease after dopamine-agonist treatment. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“We recently showed that, among all adrenal steroids, DHEAS levels are selectively increased in patients with PRL-secreting pituitary adenomas (PRLA) compared with patients with hormonally inactive pituitary adenomas and that they significantly decrease after dopamine agonists therapy, suggesting a direct effect of PRL in the regulation of DHEAS production 15 .”
What the sources say
- Supportedcites [15] Ruggiero, 2021, Integrative genomic analysis reveals a conserved role for prolactin signalling in the regulation of adrenal function, Clin Transl Med source
The paper’s patient comparison and treatment findings (Figure 4D–F) state that DHEAS levels were significantly reduced after dopamine agonist therapy in patients with PRL-secreting pituitary adenomas. The Figure 4 caption independently reports a significant decrease in the treated PRLA group (n = 22). (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Consistent with the RNA results, the CYP17A1 protein was selectively upregulated by the combined ACTH+PRL treatment and not by treatments with ACTH or PRL alone (Fig. 4).”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
16 more claims
Create a free account to see all 28 claims and every source verdict.
- Probably not a substantial claim. 3
- It may state two separate claims as one. 4
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ ACTH and PRL synergistically and selectively modulate steroid production in HFA organ cultures · p. 10
“treatment with either ACTH alone or the ACTH+PRL combination significantly increased the levels of corticosterone, cortisol and cortisone, while only the combined ACTHPRL treatment significantly increased the production of the androgens DHEAS and ∆ 4androstenedione by the HFA organ cultures (Fig. 2C).”
§ Figure legends · p. 17
“( C ) Modulation of corticosterone, cortisol, DHEAS and ∆ 4-androstenedione production by ACTH (1 nM; blue), PRL (500 ng/ml; orange) and ACTH+PRL (red) combination in HFA organ cultures.”
Citations
Cites
Pfaffl, M. W. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.e36 · Cited by 7,376
Developmental and Functional Biology of the Primate Fetal Adrenal Cortex*
Mesiano, S., & Jaffe, R. B. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0304 · Cited by 680
Soares, M. J. (2004) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-2-51 · Cited by 322
In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development
Goto, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25091 · Cited by 284
Developmental and Functional Biology of the Primate Fetal Adrenal Cortex
Mesiano, S. A. (1997) · Endocrine Reviews · doi:10.1210/er.18.3.378 · Cited by 236
Normal and Premature Adrenarche
Rosenfield, R. L. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab009 · Cited by 187
Prolactin as an autocrine/paracrine growth factor in human cancer
Ben-Jonathan, N., Liby, K., McFarland, M., & Zinger, M. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(02)00603-3 · Cited by 177
Plasma ACTH Levels in the Human Fetus and Neonate as Related to Age and Parturition1
WINTERS, A. J., OLIVER, C., COLSTON, C., MACDONALD, P. C., & PORTER, J. C. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-39-2-269 · Cited by 160
The Orphan Nuclear Receptor NGFIB Regulates Transcription of 3β-Hydroxysteroid Dehydrogenase
Bassett, M. H., Suzuki, T., Sasano, H., de Vries, C. J. M., Jimenez, P. T., Carr, B. R., & Rainey, W. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405431200 · Cited by 128
Adrenocortical function in hyperprolactinemic women
CARTER, J. N., TYSON, J. E., WARNE, G. L., McNEILLY, A. S., FAIMAN, C., & FRIESEN, H. G. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-973 · Cited by 127
Cited by
Prolactin and Adrenal Androgens During Adrenarche
Íñiguez, G., Barnafi, E., Lalli, E., Pereira, A. P. R., Ferrer‐Rosende, P., & Verónica Mericq, G. (2025) · Clinical Endocrinology · doi:10.1111/cen.15227 · Cited by 3
“We have also recently shown that prolactin has a specific action in the regulation of the production of the 11 ‐ oxygenated C19 steroids, DHEAS and androstenedione in the human fetal adrenal, in synergy with ACTH [44].”
Self-citationIsolated hypoprolactinemia: The rarest of the rare?
Khan, A. N., Dalmazi, G. D., Zahmatkeshan, K. N., & Caturegli, P. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09901-0 · Cited by 3
“In the adrenal gland, PRL regulates the expression of 17-alpha hydroxylase (cytochrome P450 family 17 subfamily A member 1) [30], the critical steroidogenesis enzyme that converts pregnenolone into 17-”
Wen, J., Zhang, F., Cheng, G., Liu, C., & Zhang, Y. (2025) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2025.2555173 · Cited by 1
“Among these hormones, insulin can stimulate androgen production in the adrenal cortex and ovaries, while ACTH and prolactin synergistically enhance androgen synthesis via upregulating the levels of DHEAS, Δ4-androstenedione, and CYP17A1 mRNA in vivo (Escobar-Morreale 2018; Schneider et al. 2023).”
Metadata
- Authors
- Schneider, G., Ruggiero, C., Renault, L., Doghman-Bouguerra, M., Durand, N., Hingrai, G., Dijoud, F., Plotton, I., & Lalli, E.
- Affiliations
- Lyon 1 Université (FR)
- Centre National de la Recherche Scientifique (FR)
- Institut de Pharmacologie Moléculaire et Cellulaire CNRS UMR 7275 , 06560 Valbonne , France
- Hospices Civils de Lyon (FR)
- Corresponding author
- Plotton, Ingrid
- Lalli, Enzo
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-08-28
- Volume
- 189
- Issue
- 3
- Pages
- 327-335
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W4386209268
- Cited by
- 3
- References
- 40
- Citations by year
- 2025: 2 · 2024: 1
- FWCI
- 0.61
- Type
- journal article
- Language
- en
- Open access
- green
- hal.science
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- Fondation ARC Project
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- ACTH, prolactin, CYP17A1, adrenal androgen production, steroidogenesis, dehydroepiandrosterone sulfate, Δ4-androstenedione, corticosteroids, first trimester
- MeSH terms
- Adrenocorticotropic Hormone, Androgens, Humans, Organ Culture Techniques, Prolactin, Steroid 17-alpha-Hydroxylase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ACTH and prolactin synergistically and selectively regulate CYP17 expression and adrenal androgen production in human foetal adrenal organ cultures. https://app.cochat.ai/papers/10.1093/ejendo/lvad118
- The paper
- Schneider, G., Ruggiero, C., Renault, L., Doghman-Bouguerra, M., Durand, N., Hingrai, G., Dijoud, F., Plotton, I., & Lalli, E. (2023). ACTH and prolactin synergistically and selectively regulate CYP17 expression and adrenal androgen production in human foetal adrenal organ cultures. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvad118
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.